284

Chemours opens battery lab

16th August 2024

Submitted by:

Andrew Warmington

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Chemours publishes initial findings of review

14th March 2024

Submitted by:

Andrew Warmington

The Audit Committee of the Chemours board has delivered a “substantially complete” report of the findings of the internal review it was tasked to complete with regard to the conduct of CEO Mark New

Chemours places three on leave during review

1st March 2024

Submitted by:

Andrew Warmington

The board of Chemours has put CEO Mark Newman, CFO Jonathan Lock and principal accounting officer Camela Wisel on administrative leave pending the completion of an internal review by independent co

Chemours to close plant in Taiwan

1st August 2023

Submitted by:

Andrew Warmington

During its Q2 results presentation, Chemours announced a decision to close its Kuan Yin TiO2 manufacturing facility in Taiwan (pictured).

Three pay to settle PFAS claims

8th June 2023

Submitted by:

Andrew Warmington

Chemours, DuPont and Corteva have reached an agreement in principle to resolve all per- and polyfluoroalkyl substance (PFAS)-related drinking water claims of a defined class of public water systems

ECHA publishes PFAS restriction proposal

9th February 2023

Submitted by:

Andrew Warmington

The European Chemicals Agency (ECHA) has published a proposed restriction of around 10,000 per- and polyfluoroalkyl substances (PFAS) on its website.

Chemours expands ion exchange materials

13th January 2023

Submitted by:

Andrew Warmington

Chemours is to invest $200 million to increase capacity and advance technology for its Nafion brand ion exchange materials at the site in Villers-Saint-Paul, France.

Chemours invests in hydrogen economy

4th October 2022

Submitted by:

Andrew Warmington

Chemours has announced a planned $200 million investment to increase capacity and advance technology for its industry-leading Nafion ion exchange materials.

Subscribe to Chemours